Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-03-05 Sale | 2024-03-06 6:45 pm | Tenaya Therapeutics Inc. | TNYA | Hoey Timothy Chief Scientific Officer | 3,300 | $7.0003 | $23,101 | 245,346 (Direct) | View |
2024-02-20 Sale | 2024-02-21 6:05 pm | Tenaya Therapeutics Inc. | TNYA | Hoey Timothy Chief Scientific Officer | 6,569 | $5.3351 | $35,046 | 236,146 (Direct) | View |
2024-02-16 Sale | 2024-02-16 8:37 pm | Tenaya Therapeutics Inc. | TNYA | Hoey Timothy Chief Scientific Officer | 4,681 | $5.86 | $27,431 | 242,715 (Direct) | View |
2024-02-16 Sale | 2024-02-16 8:35 pm | Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer | 6,500 | $5.86 | $38,090 | 73,534 (Direct) | View |
2024-02-16 Sale | 2024-02-16 8:32 pm | Tenaya Therapeutics Inc. | TNYA | PATTERSON LEONE D Chief Fin. and Bus. Officer | 5,201 | $5.86 | $30,478 | 60,755 (Direct) | View |
2024-02-16 Sale | 2024-02-16 8:30 pm | Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer | 6,358 | $5.86 | $37,258 | 113,079 (Direct) | View |
2024-02-12 Purchase | 2024-02-14 4:15 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 2,222,222 | $4.5 | $9,999,999 | 22,999,565 (Indirect) | View |
2024-02-12 Purchase | 2024-02-14 4:12 pm | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 2,222,222 | $4.5 | $9,999,999 | 22,999,565 (Indirect) | View |
2023-08-29 Sale | 2023-08-29 6:59 pm | Tenaya Therapeutics Inc. | TNYA | Hoey Timothy Chief Scientific Officer | 7,243 | $4.26 | $30,855 | 247,396 (Direct) | View |
2023-08-16 Sale | 2023-08-18 6:34 pm | Tenaya Therapeutics Inc. | TNYA | Hoey Timothy Chief Scientific Officer | 4,007 | $3.81 | $15,267 | 254,639 (Direct) | View |
2023-08-16 Sale | 2023-08-18 6:33 pm | Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer | 5,563 | $3.81 | $21,195 | 76,437 (Direct) | View |
2023-08-16 Sale | 2023-08-18 6:31 pm | Tenaya Therapeutics Inc. | TNYA | PATTERSON LEONE D Chief Fin. and Bus. Officer | 4,452 | $3.81 | $16,962 | 64,542 (Direct) | View |
2023-08-16 Sale | 2023-08-18 6:31 pm | Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer | 5,563 | $3.81 | $21,195 | 119,437 (Direct) | View |
2023-03-10 Purchase | 2023-03-14 4:12 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 6,779 | $2.5956 | $17,596 | 20,777,343 (Indirect) | View |
2023-03-10 Purchase | 2023-03-14 4:09 pm | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 6,779 | $2.5956 | $17,596 | 20,777,343 (Indirect) | View |
2023-02-08 Purchase | 2023-02-10 4:32 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 1,500,000 | $2.6 | $3,900,000 | 20,770,564 (Indirect) | View |
2023-02-08 Purchase | 2023-02-10 4:22 pm | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 1,500,000 | $2.6 | $3,900,000 | 20,770,564 (Indirect) | View |
2023-01-19 Purchase | 2023-01-23 4:25 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 69,739 | $2.4979 | $174,201 | 19,270,564 (Indirect) | View |
2023-01-19 Purchase | 2023-01-23 4:21 pm | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 69,739 | $2.4979 | $174,201 | 19,270,564 (Indirect) | View |
2023-01-17 Purchase | 2023-01-19 4:18 pm | Tenaya Therapeutics Inc. | TNYA | COLUMN GROUP III GP LP COLUMN GROUP III LP COLUMN GROUP III-A LP Column Group Opportunity III LP Column Group Opportunity III GP LP TCG Opportunity III GP LLC 10% Owner | 185,151 | $2.5105 | $464,827 | 19,200,825 (Indirect) | View |
2023-01-17 Purchase | 2023-01-19 4:13 pm | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 185,151 | $2.5105 | $464,827 | 19,200,825 (Indirect) | View |
2022-11-21 Purchase | 2022-12-09 7:59 pm | Tenaya Therapeutics Inc. | TNYA | Srivastava Deepak Director | 230,769 | $2.6 | $599,999 | 564,101 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-02-23 Option Award | 2024-02-27 7:31 pm | 2024-03-23 2034-02-22 | Tenaya Therapeutics Inc. | TNYA | Hoey Timothy Chief Scientific Officer | 87,500 | $0 | 323,646 (Direct) | View |
2024-02-23 Option Award | 2024-02-27 7:30 pm | 2024-03-23 2034-02-22 | Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer | 250,000 | $0 | 323,534 (Direct) | View |
2024-02-23 Option Award | 2024-02-27 7:29 pm | 2024-03-23 2034-02-22 | Tenaya Therapeutics Inc. | TNYA | PATTERSON LEONE D Chief Fin. and Bus. Officer | 240,000 | $0 | 300,755 (Direct) | View |
2024-02-23 Option Award | 2024-02-27 7:28 pm | 2024-03-23 2034-02-22 | Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer | 590,000 | $0 | 703,079 (Direct) | View |
2023-06-09 Option Award | 2023-06-12 8:41 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | Walsh Jeffrey T. Director | 29,532 | $0 | 29,532 (Direct) | View |
2023-06-09 Option Award | 2023-06-12 8:38 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | Williams R Sanders Director | 29,532 | $0 | 29,532 (Direct) | View |
2023-06-09 Option Award | 2023-06-12 8:34 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | Stehman-Breen Catherine Director | 29,532 | $0 | 29,532 (Direct) | View |
2023-06-09 Option Award | 2023-06-12 8:30 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | Srivastava Deepak Director | 29,532 | $0 | 29,532 (Direct) | View |
2023-06-09 Option Award | 2023-06-12 8:24 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | Parschauer Karah Herdman Director | 29,532 | $0 | 29,532 (Direct) | View |
2023-06-09 Option Award | 2023-06-12 8:17 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | Lee June Director | 29,532 | $0 | 29,532 (Direct) | View |
2023-06-09 Option Award | 2023-06-12 8:14 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | GOEDDEL DAVID V Director 10% Owner | 29,532 | $0 | 29,532 (Direct) | View |
2023-06-09 Option Award | 2023-06-12 8:10 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | CHEN JIN-LONG Director | 29,532 | $0 | 29,532 (Direct) | View |
2023-06-09 Option Award | 2023-06-12 8:09 pm | 2024-06-09 2033-06-08 | Tenaya Therapeutics Inc. | TNYA | Burroughs Amy L. Director | 14,766 | $0 | 14,766 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 6:48 pm | 2023-03-15 2033-02-14 | Tenaya Therapeutics Inc. | TNYA | Hoey Timothy Chief Scientific Officer | 205,000 | $0 | 433,646 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 6:47 pm | 2023-03-15 2033-02-14 | Tenaya Therapeutics Inc. | TNYA | Tingley Whittemore Chief Medical Officer | 285,000 | $0 | 285,000 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 6:45 pm | 2023-03-15 2033-02-14 | Tenaya Therapeutics Inc. | TNYA | PATTERSON LEONE D Chief Fin. and Bus. Officer | 255,000 | $0 | 257,000 (Direct) | View |
2023-02-15 Option Award | 2023-02-17 6:43 pm | 2023-03-15 2033-02-14 | Tenaya Therapeutics Inc. | TNYA | Ali Faraz Chief Executive Officer | 800,000 | $0 | 800,000 (Direct) | View |
2022-12-05 Option Award | 2022-12-07 6:20 pm | 2023-01-05 2032-12-04 | Tenaya Therapeutics Inc. | TNYA | Burroughs Amy L. Director | 40,000 | $0 | 40,000 (Direct) | View |